Postnatal decrease in substantia nigra echogenicityImplications for the pathogenesis of Parkinson’s disease

被引:0
|
作者
Alexander Iova
Andrew Garmashov
Natalia Androuchtchenko
Martin Kehrer
Daniela Berg
Georg Becker†
Yurii Garmashov
机构
[1] Saint-Petersburg Medical Academy of Postgraduate Education,Departments of Child Neurology and Neonatology
[2] Department of Child Neurology and Neurosurgery,Department of Neurology
[3] University Children’s Hospital,undefined
[4] Saarland University,undefined
[5] Institute for Medical Genetics,undefined
[6] Hertie Institute for Clinical Brain Research,undefined
来源
Journal of Neurology | 2004年 / 251卷
关键词
Parkinson’s disease; iron metabolism; transcranial ultrasound;
D O I
暂无
中图分类号
学科分类号
摘要
Increased echogenicity of the substantia nigra (SN) on transcranial ultrasonography (TCS) is a typical sign in Parkinson’s disease (PD). Detected in healthy adults it is assumed to represent a risk factor for nigral injury. We studied at which time point of brain maturation increased signal intensity may occur by performing TCS scans in 109 newborns and children aged 0–192 months. While newborns regularly exhibit SN hyperechogenicity, this echofeature decreases substantially during the first years of life. As SN echogenicity is related to the tissue iron content in adults our findings suggest a failure in SN iron metabolism in some children with increased echogenicity during development which can be disclosed by TCS.
引用
收藏
页码:1451 / 1454
页数:3
相关论文
共 50 条
  • [21] Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's Disease
    Prasuhn, Jannik
    Strautz, Robert
    Lemmer, Felicitas
    Dreischmeier, Shalida
    Kasten, Meike
    Hanssen, Henrike
    Heldmann, Marcus
    Brueggemann, Norbert
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) : 1191 - 1200
  • [22] Magnetic resonance imaging of the substantia nigra in Parkinson's disease
    Lehericy, Stephane
    Sharman, Michael A.
    Dos Santos, Clarisse Longo
    Paquin, Raphael
    Gallea, Cecile
    MOVEMENT DISORDERS, 2012, 27 (07) : 822 - 830
  • [23] Proteome analysis of human substantia nigra in Parkinson's disease
    Basso, M
    Giraudo, S
    Corpillo, D
    Bergamasco, B
    Lopiano, L
    Fasano, M
    PROTEOMICS, 2004, 4 (12) : 3943 - 3952
  • [25] Imaging of Substantia Nigra in Parkinson's Disease: A Narrative Review
    Feraco, Paola
    Gagliardo, Cesare
    La Tona, Giuseppe
    Bruno, Eleonora
    D'angelo, Costanza
    Marrale, Maurizio
    Del Poggio, Anna
    Malaguti, Maria Chiara
    Geraci, Laura
    Baschi, Roberta
    Petralia, Benedetto
    Midiri, Massimo
    Monastero, Roberto
    BRAIN SCIENCES, 2021, 11 (06)
  • [26] No evidence of substantia nigra telomere shortening in Parkinson's disease
    Hudson, Gavin
    Faini, David
    Stutt, Andrea
    Eccles, Martin
    Robinson, Louise
    Burn, David J.
    Chinnery, Patrick F.
    NEUROBIOLOGY OF AGING, 2011, 32 (11) : 2107.e3 - 2107.e5
  • [27] Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: no
    Uwe Walter
    Journal of Neural Transmission, 2011, 118 : 607 - 612
  • [28] Substantia nigra echogenicity in Parkinson’s disease: relation to serum iron and C-reactive protein
    Uwe Walter
    Rike Witt
    Alexander Wolters
    Matthias Wittstock
    Reiner Benecke
    Journal of Neural Transmission, 2012, 119 : 53 - 57
  • [29] Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra
    Felletschin, B
    Bauer, P
    Walter, U
    Behnke, S
    Spiegel, J
    Csoti, I
    Sommer, U
    Zeiler, B
    Becker, G
    Riess, O
    Berg, D
    NEUROSCIENCE LETTERS, 2003, 352 (01) : 53 - 56
  • [30] Substantia nigra echogenicity in Parkinson's disease: relation to serum iron and C-reactive protein
    Walter, Uwe
    Witt, Rike
    Wolters, Alexander
    Wittstock, Matthias
    Benecke, Reiner
    JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (01) : 53 - 57